Ardelyx Inc. (ARDX) Soars 13.1% on March 17

Equities Staff  |

Ardelyx Inc. (ARDX) had a good day on the market for Tuesday March 17 as shares jumped 13.1% to close at $4.92. About 808,641 shares traded hands on 6,634 trades for the day, compared with an average daily volume of n/a shares out of a total float of 88.93 million. After opening the trading day at $4.45, shares of Ardelyx Inc. stayed within a range of $4.98 to $4.38.

With today's gains, Ardelyx Inc. now has a market cap of $437.53 million. Shares of Ardelyx Inc. have been trading within a range of $8.82 and $2.10 over the last year, and it had a 50-day SMA of $n/a and a 200-day SMA of $n/a.

Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis.

Ardelyx Inc. is based out of Fremont, CA and has some 88 employees. Its CEO is Michael G. Raab.

For a complete fundamental analysis of Ardelyx Inc., check out’s Stock Valuation Analysis report for ARDX.

Still paying commissions on stock trades? now offers $7.99/month unlimited trading and flat-fee options trading for $89.99/month! Get started today by

Ardelyx Inc. is also a component of the Russell 2000. The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

To get more information on Ardelyx Inc. and to follow the company’s latest updates, you can visit the company’s profile page here: ARDX’s Profile. For more news on the financial markets and emerging growth companies, be sure to visit’s Newsdesk. Also, don’t forget to sign-up for our daily email newsletter to ensure you don’t miss out on any of our best stories.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:



Symbol Last Price Change % Change